Form 4 Filing for Bioventus Inc.

This filing details transactions by Mark Leonard Singleton, SVP & CFO of Bioventus Inc. On April 10, 2026, Mr. Singleton acquired 13,000 Restricted Stock Units (RSUs) with a transaction price of $0.00. These RSUs are convertible into Class A Common Stock, with each RSU representing one share. The RSUs vest in four equal annual installments starting April 10, 2023, contingent upon continued service. Following this acquisition, Mr. Singleton was granted 13,000 RSUs. Concurrently, there was a disposition of 5,648 shares of Class A Common Stock at a price of $9.06 per share. The post-transaction holdings indicate 182,981 shares after the acquisition and 177,333 shares after the disposition.